Brief: Poolbeg Pharma Identifies Potential Drug Candidates For Respiratory Syncytial Virus Infections
21/12/2022 07:28
Dec 21 (Reuters) - Poolbeg Pharma PLC POLB.L :
* POOLBEG PHARMA PLC - IDENTIFIES NEW POTENTIAL DRUG
CANDIDATES
FOR RESPIRATORY SYNCYTIAL VIRUS INFECTIONS AS PART OF ARTIFICIAL
INTELLIGENCE PROGRAMME
Source text for Eikon: ID:nRSU3928Ka
Further company coverage: POLB.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Poolbeg Pharma
See all newsBrief: Poolbeg Pharma Says European Patent Granted For POLB 001 In CRS
PDMR Notification
Brief: Poolbeg Pharma Says FDA Feedback Broadly Aligned With Development Pathway For POLB 001
Brief: Poolbeg Pharma Announces Granted POLB 001 Cancer Immunotherapy-Induced CRS Patent In Canada
Annual Report & AGM Notice